FOXA2 and breast carcinoma: Using subcellular fractionation in three breast cancer cell lines, MDA-MB-231, MCF7, and ZR75, we found that, in mesenchymal breast cancer cell line MDA-MB-231, the cytosolic expression of FOXA2 was higher compared to the nucleus.